StreetAlpha.app
Home › Stocks › CDNA

CareDx, Inc. (CDNA)

Healthcare
$74.56
▲ +1.14%
LAST CLOSE · NOV 17

CareDx provides transplant testing, donor matching products, software and pharmacy services for transplant centers and patients. It last closed at $74.56 on Nov 17, up 1.14% on the day. The average 12-month price target from 3 analysts is $90.67 (+21.6% from the last close), with a high of $100.00 and a low of $80.00. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in CDNA, 0% of them bullish and 100% bearish.

AI Auto Pilots
Is CDNA in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$497.4M
+38.9% vs a year ago
Net income
$128.6M
+82.6% vs a year ago
EPS (diluted)
$2.37
+85.2% vs a year ago
Operating margin
23.4%
$116.5M operating income
Valuation
Market cap
$3.9B
52.5M shares
P/E
31.5
Price over 12 month EPS
Price to sales
7.9
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$250.5M
At Sep 30
Shareholder equity
$467.5M
Buybacks
$24.4M
Last 12 months
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $296.4M$296.4MFY2021FY2022: $321.8M$321.8MFY2022FY2023: $280.3M$280.3MFY2023FY2024: $333.8M$333.8MFY2024FY2025: $379.8M$379.8MFY2025

From CDNA's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 29). Last 12 months adds up the four latest quarters.

Next report
—
No date on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
Strong Buy
Based on 3 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
3firms
3 Buy0 Hold0 Sell
Each firm's latest rating on CDNA in the past 90 days
Average 12-month target
$90.67
▲ 21.6% upside

Based on 3 analysts who set a price target on CDNA in the past 90 days. The average target is $90.67, with a high of $100.00 and a low of $80.00, compared with the last close of $74.56.

Low $80.00Avg $90.67High $100.00
Blue marker: last close $74.56
Highest target$100.00
Average target$90.67
Lowest target$80.00
Latest rating changes
Piper SandlerInitiated
Nov 11Buy$100
BTIGTarget raised
Oct 30Buy$81 → $92
BTIGTarget raised
Oct 27Buy$74 → $81
Canaccord GenuityTarget raised
Oct 19Buy$65 → $80
BTIGTarget raised
Sep 24Buy$60 → $74
DateFirmActionRatingPrice target
Nov 11Piper SandlerInitiatedBuy$100
Oct 30BTIGTarget raisedBuy$81 → $92
Oct 27BTIGTarget raisedBuy$74 → $81
Oct 19Canaccord GenuityTarget raisedBuy$65 → $80
Sep 24BTIGTarget raisedBuy$60 → $74
Loading…

Technical Analysis

CDNA · as of the Nov 17 close · updated after every close
Uptrend

The stock sits between its 20 and 50 day averages. It is 50% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 50). The nearest support is the Pivot at $74.05, and the nearest resistance the Pivot R1 at $75.95.

Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityHigh, 6.7%/day
Key levels
$90.8752 week high+21.9%
$90.87Swing high (Oct 30)+21.9%
$77.3620 day average+3.8%
$75.95Pivot R1+1.9%
$74.56Last close
$74.05Pivot−0.7%
$72.65Pivot S1−2.6%
$67.2850 day average−9.8%
$61.19Swing low (Oct 8)−17.9%
$54.21100 day average−27.3%
$37.24200 day average−50.1%
$15.1552 week low−79.7%
Indicators
RSI (14)50.20Middle of its rangeNeutral
MACD3.06Below its signal lineBearish
Stochastic28.4Middle of its rangeNeutral
ADX (14)39.8Trending up
Williams %R-78.0Oversold below −80, overbought above −20Neutral
CCI (20)-40.0Oversold below −100, overbought above 100Neutral
Rate of change−15.7%Change over 10 sessionsBearish
ATR (14)$5.03Typical daily range, 6.7% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for CDNA

What happened before

See how CDNA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow CDNA usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How CDNA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2014.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
1
Bullish
0
0%
Bearish
1
100%
Date span
Oct 30 – Oct 30
Loading…

See today’s whale options flow across the market →

CDNA Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲193 buying vs 110 selling
  • ▼Held by funds -2.7 pts
  • ▲Funds holding +79
  • ▲Superinvestors: 4 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding308229+34.5%
In funds' top 1054+25.0%
Held by funds99.0%101.6%−2.7 pts
New / increased102 / 9152 / 76+50.8%
Reduced / sold out87 / 2368 / 13+35.8%
Put/call ratio0.00––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See CDNA institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CDNA is in one of them and how their past CDNA trades turned out.

CDNA in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CDNA in an article yet. Here's the latest on the wider market.

CDNA Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Apr 17
Who traded CDNA · since 2019
Latest 5 filings of 6
$1K – $15KTraded Mar 6, 2023Filed Apr 17, 2023
$15K – $50KTraded Mar 2, 2021Filed Apr 10, 2021
$1K – $15KTraded Jun 19, 2019Filed Mar 5, 2021
$1K – $15KTraded Jun 17, 2019Filed Mar 5, 2021
$1K – $15KTraded Apr 1, 2019Filed Mar 5, 2021
PersonTypeAmountTradedFiledDelay
Dan GoldmanD · NYSell$1K – $15KMar 6, 2023Apr 17, 202342 d
Tom MalinowskiD · NJBuy$15K – $50KMar 2, 2021Apr 10, 202139 d
Tom MalinowskiD · NJSell$1K – $15KJun 19, 2019Mar 5, 2021625 d
Tom MalinowskiD · NJSell$1K – $15KJun 17, 2019Mar 5, 2021627 d
Tom MalinowskiD · NJBuy$1K – $15KApr 1, 2019Mar 5, 2021704 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About CareDx

CareDx is a company that offers testing and software for transplant patients and the clinicians who treat them. Its tests check heart, kidney and lung transplant recipients for signs of organ rejection after surgery. The company also sells products that help match donors and recipients before a transplant, software that helps transplant centers manage patient lists and workflow, and specialized pharmacy services for transplant patients. Its main customers are transplant centers, and it is based in Brisbane, California.

Headquarters
Brisbane, CA
Founded
2000